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INTRODUCTION 
 
 High resolution cross sectional imaging of the retina is useful 
for identifying, monitoring and quantitatively assessing macular 
diseases.  Optical Coherence Tomography (OCT) is a new medical 
diagnostic imaging technology which can perform micron resolution, 
cross sectional or tomographic imaging in biological tissues.  Cross 
sectional images of the retina are obtained at the resolution of 10 
microns.  OCT uses low coherence or white light interferometry to 
perform high resolution measurements and imaging.  The infra red 
light beam has a wavelength of 820 nm. 
 
 Post Operative Cystoid Macular Edema (CME) frequently 
occurs following cataract surgery.  It can also occur following YAG 
capsulotomy, Cryo, Laser photocoagulation, scleral buckling and 
Penetrating Keratoplasty (PKP).  Cystoid macular edema is the 
result of accumulation of fluid in the outer plexiform and inner 
nuclear layers of the retina centrered about the foveala and 
formation of fluid filled cyst like changes.  OCT offers an objective 
test for quantitative evaluation of patients with CME.  OCT can 
quantitatively assess retinal thickness and demonstrate any 
associated RPE structural anomalies beneath edematous retina 
which can be obscured by leakage on angiography.  
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 Measurement of retinal thickness by OCT correlate more 
strongly with visual acuity than presence of leakage on 
angiography. 
 
 The aim of the present dissertation is to study optical 
coherence tomographic features in post operative CME and monitor 
it with OCT. 
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AIM OF THE STUDY 
 
1. To study the optical coherence tomography features of 
post operative CME. 
2. To assess the role of optical coherence tomography in 
monitoring, diagnosis and followup of cystoid macular 
edema.  
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REVIEW OF LITERATURE 
 
Anatomy of the Macula 
 Macula refers to that part of central retina having a diameter 
of 5.5 mm and limited by the outer boundary of the perifovea where 
ganglion cells are reduced to single layer. 
 
Parts of the Macula 
• Umbo 
• Foveola 
• FAZ 
• Fovea 
• Parafoveal area 
• Perifoveal area 
 
Umbo 
 It is a tiny depression in the very centre of the foveola which 
corresponds to ophthalmoscopically visible foveolar reflex. 
 
Foveola (350 µ) 
 It is the small central region in which thickness of retina is 
reduced so as to contain only photoreceptors, glial cells and 
Muller’s cells. 
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Fig. 1.  Topography of Macula 
 
 
 
 
 
 
Fig. 2. Histology of Macula 
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Foveal Avascular Zone (FAZ – 800 µ) 
 It is located inside the fovea but outside the foveola. 
 
Fovea (1500 µ) 
 It is a small depression in which retina is reduced to about half 
its normal thickness.  Moving towards the centre of retina, the inner 
nuclear layer is reduced to double row of cells at the edge of fovea. 
 
Parafoveal Area (500 µ) 
 It is characterized by densest accumulation of nerve cells in 
entire retina; especially ganglion cells and inner nuclear layer.  The 
outer boundary is the part where ganglion cell layer has four rows of 
nuclei. 
 
Perifoveal Area (1500 µ) 
 It ends where the ganglion cells are reduced to a single layer. 
 
Histology of the Macula 
 The centre of the macula is the fovea containing following 
layers. 
• Internal limiting membrane 
• Outer plexiform layer 
• Outer nuclear layer 
• Layer of cones 
• Retinal Pigment Epithelium (RPE) 
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Histological Review 
 Cystoid macular edema1,2,31,56 is still the most frequent cause 
of decreased vision, 1 to 3 months following cataract surgery.  
However, its incidence has declined with advances in surgical 
techniques (most notable, the change from ICCE to ECCE). 
 
 Clinical CME has histologically been defined as a reduction in 
vision to 20/40 or less that is attributable to ophthalmoscopically or 
angiographically visible CME.37,63  The condition occurs in as many 
as 1% - 6% of patients after uncomplicated phaco surgery.3,4,7   
 
 In 1953, Irvine5,34,59 described a syndrome that now bears his 
name.  By definition, this condition included improvement of vision 
after cataract surgery followed by dimunition of vision associated 
with post operative rupture of anterior hyaloid membrane with or 
without adherence of vitreous to surgical wound. 
 
 Approximatley 1% of patients may develop CME after Nd-
YAG capsulotomy.49  This complication occurs after 1 – 5 months 
later and is believed to be related to opening of the posterior 
capsule rather than to the energy of Nd : YAG laser. 
 
 It is also common after other surgeries such as glaucoma 
procedures, vitrectomy, penetrating kerotoplasty (KP) and retinal 
detachment (RD) surgery.33 
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Mechanism1,42,43,47 
Uveal stimulation or release of lens epithelial cells  
during intraocular surgery 
↓ 
Prostaglandins synthesis in Anterior chamber 
↓ 
Disturbance of blood aqueous barrier 
↓ 
Release of Cytokines and other inflammatory mediator in AC 
↓ 
Diffuses to vitreous 
↓ 
Breakdown in inner Blood – retinal barrier that leads to CME50-52 
(higher in older patients and those with various ocular conditions) 
 
Risk Factors8,34,61 
 In cataract surgery, risk of post operative CME appears to be 
lower with Phacosurgery (0.2 – 1.4%) than ECCE (20%) or ICCE 
(60%). 
 
 A PC rent with vitreous loss is associated with 11.5% - 20% 
incidence of clinical CME in patients undergoing 
phacoemulsification and 30.8% in ECCE.46,55,58 
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 In retained lens fragments, the risk of CME is 29% after 
phacoemulsification.41 
 
 In AC IOLs, it is seen more in rigid type and lower with well 
positioned open loop types.40 
 
 In Nd : YAG capsulotomy, 1% develop complications which is 
1 – 4 months later and usually due to opening of posterior 
capsule.57 
 
 Jaffe Chamblers12,32 reported a low incidence of CME and RD 
in blacks a fact difficult to explain.   
 
Definite risk factors are :15 
• Diabetes  
• Older Age 
• Uveitis 
 
Clinical Features 
Following surgery first improvement, then drop in visual 
acuity. 
 
Slit Lamp Biomicroscopy of Fundus12,44 
• Loss of foveal depression, thickening of retina and multiple 
cystoid spaces in sensory retina. 
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• In many early cases cystoid changes may be difficult to 
discern and the main finding is yellowish spot at fovea. 
 
Indirect Ophthalmoscopy14,48,54 
• Good overall view of retina is seen and this is of value in 
detecting areas of eccentric retinal thickening, if present.  
 
FFA20 
• The arteriovenous phase shows mild parafoveal hyper 
fluorescence due to early leakage. 
• The late venous phase shows increasing hyper fluorescence 
and coalescence of foveal leaks. 
• The late phase shows a flower petal pattern of hyper 
fluorescence caused by accumulation of dye within  
microcystic spaces in outer plexiform layer of retina with 
radical arrangement of fibres about centre of foveola. 
 
Vitreous Fluorophotometry 
• Developed by Cunha Vaz et al.6 particularly very useful in 
aphakic CME. 
• Normally only small amount of fluorescein will gain entry to 
the vitreous because of presence of blood retinal barrier.  
Increased fluorescence leakage in vitreous can be detected in 
post operative CME. 
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OCT15 
 It shows intraretinal cystic spaces and occasionally a small 
amount of Sub Retinal Fluid (SRF). 
 
 OCT may be sufficient for diagnosis in patients whose 
presentation is classic.17  In diabetics or patients with an atypical 
presentation, however FFA assists the diagnosis by ruling out other 
causes of macular edema such as Diabetic Retinopathy (DR), 
venous occlusive disease, Choroidal Neovascular Membrane 
(CNVM), idiopathic juxtafoveal retinal telengietasia. 
 
 Hyper fluorescence of the optic disc is typically present in post 
operative CME, but this clinical sign is often absent in other 
etiologies, including Clinically Significant Macular Edema (CSME), 
epiretinal membrane or Age Related Macular Degeneration 
(ARMD). 
 
 OCT helps in ruling out macular edema due to Retinal 
Detachment (RD), Central Retinal Vein Occlusion (CRVO), Diabetic 
Retinopathy (DR), epiretinal membrane or Vitreo Macular Traction. 
 
 FFA rules out CNVM / Juxtra foveal telengiectasia. 
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Optical Coherence Tomography22 
 Optical Coherence Tomography is a new diagnostic tool that 
can perform tomography / cross -sectional imaging of biological 
tissues with ≤ 10 microns axial resolution using light waves. 
 
Principle 
It uses infra red light. The speed of light-is almost a million 
times faster than sound and this difference - allows the 
measurement of structures with resolution of ≤ 10 microns 
compared to 100 micron scale of ultrasound. Ultrasound needs 
contact with the tissue under study, whereas OCT does not, require 
any contact. 
 
It is a non- contact, non- invasive device where a broad band-
width of near infra-red light beam (820nm) is projected on to the 
retina. The light gets reflected from the boundaries between the 
microstructure and also gets scattered differently from tissues with 
different optical properties. It then compares the echo time delay of 
the same wavelength that is reflected from a reference mirror at a 
known distance. 
 
Optical coherence tomography uses, low coherence or white 
light interferometry to perform high resolution measurements and 
imaging. 
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An optical beam from a laser or light source which emits short 
optical pulses or short coherence length light, is directed onto a 
partially reflecting mirror (optical beam splitter). The partially 
reflecting mirror splits the light into two beams, one beam is 
reflected and the other is transmitted. One light beam is directed on 
to the patients eye and is reflected from intraocular structures at 
different distances. 
 
The reflected light beam from the patient's eye consists of 
multiple echoes which give information about the range or distance 
and thickness of different intra-ocular structures. The second beam 
is reflected from a reference mirror at a known spatial position. This 
retro-reflected reference optical beam travels, back to the partial 
mirror (beam splitter) where it combines into the optical beam 
reflected from the patient's eye. 
 
When the two light pulses coincide they produce a 
phenomenon known as interference which is measured by a light 
sensitive detector (photodetector). Thus the interferometer can 
precisely measure the echo structure of reflected light and perform 
high resolution measurements of the distance and thickness of 
different tissue structures. 
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Fig. 3.  Schematic diagram of the optical coherence tomography system. 
Axial profiles of backscattering (A-scans) within the eye are measured by translating 
the reference mirror and recording the interferometric signal. Cross-sectional 
tomographs of optical reflectivity are constructed analogous to ultrasound B-scan by 
scanning the probe beam across the fundus. 
 
 The key feature of interferometer is that it can measure the 
time delay of optical echoes by comparing the reflected light beam 
with a reference beam. While the explanation presented here 
assumes that the light is composed of short optical pulses, the 
measurement may also be performed using non-pulsed or 
continuous light with a short coherence length. For this reason, the 
measurement techniques has been termed 'low coherence 
interferometry'. 
 
 The light source for the interferometer is a compact super 
luminescent diode, which is coupled directly into an optical fibre. 
This light source is similar to laser diode used in optical compact 
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disc players, except in OCT, the diode source is designed to emit 
short coherence length light. The interferometer is constructed using 
a fibre optic coupler which functions, analogous to a beam splitter. 
The arm of the interferometer which consists of reference mirror is 
located within the instrument, while the optical fibre in the second 
arm of the interferometer is connected to the OCT ophthalmic 
instrument resembling a slit lamp biomicroscope or fundus camera. 
 
Image Resolution23 
The image resolution of OCT in the axial (or longitudinal) 
verses transverse directions is determined by different mechanisms. 
The resolution of the image in the axial (longitudinal) direction is 
determined by the resolution of the optical ranging measurement. 
This is determined by the physical properties of light source which is 
used for the measurement. If a short pulse laser source is used, the 
axial resolution is determined by the pulse duration. Conversely, if a 
continuous, low-coherence light source is used, the axial resolution 
is determined by the 'coherence length' of the light source. It is 
important to note  that the measurement of distance or tissue 
thickness can, in practice, be performed with significantly higher 
resolution than this limit. 
 
The transverse resolution of the image is determined by the 
size of the focused optical beam. This is a function of the optics 
used to project the beam onto the eye and this is determined by 
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factors such as whether imaging is performed over a large depth, 
such as in the anterior eye, or whether the focusing angle is 
restricted, as in imaging the retina. The image resolution is also a 
function of the size of the tomogram that is desired. 
 
OCT Scan Protocols in Macula21,26,29,30 
The protocols that are helpful in macular diseases are the 
following : 
 
(i) Line Scan 
 The line scan gives an option of acquiring multiple line scan 
without returning to main window. The length of the line scan and 
the angle can be altered, though one has to keep in mind that as the 
scan length increases the resolution decreases. 
 
(ij) Radial lines 
 The scan protocol consists of 6 - 24 equally spaced line scans 
that can be varied in size and parameters. All the lines pass through 
a central common axis. The radial lines are useful for acquiring 
macular scan and retinal thickness / volume analysis. 
 
(iii) Macular thickness map 
This is the same as radial lines except that the aiming circle 
has a fixed, diameter of 6 mm. This helps in measuring the retinal 
thickness. 
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(iv) Fast macular thickness map 
it is designed for use with retinal thickness analysis. When 
done in both the eyes, it can be used for comparative retinal 
thickness / volume analysis. It is a quick protocol that takes only 
1.92 sec to acquire six scans of 6 mm length each. 
 
(v)  Raster line 
 This provides an option of acquiring series of line scans that 
are parallel, equally spaced and are 6 - 24 in number. These 
multiple line scans are placed over rectangular regions, the area of 
which can be adjusted so as to cover the entire area of pathology. 
This is especially useful in conditions like choroidal neovascular 
membrane where one wishes to obtain scans at multiple levels. 
 
(vi)  Repeat 
Repeat protocol enables one to repeat any of the previously 
saved protocols using same set of parameters, that includes scan 
size, angle, placement of fixation, light emitting diode (LED) and 
landmark. 
 
Normal macular scan 
On a 10 mm horizontal line scan passing through the foveal 
centre, one can clearly demarcate two major landmarks namely 
optic disc and fovea. 
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 The optic disc is seen towards the right of the tomogram and 
is easily identifiable by its contour. The central depression 
represents the optic head cup and the stalk continuing behind is the 
anterior part of the optic nerve. The fovea is seen to the left and is 
easily identifiable by the characteristic thinning of retinal layers. The 
vitreous anterior to the retina is non-reflective and is seen as a dark 
space. The interface between the non-reflective vitreous and back 
scattering retinal layers is the vitreoretinal interface. The retinal 
nerve fibre layer (NFL) is highly reflective and increases in thickness 
towards the optic nerve. The posterior boundary of the retina is 
marked by a hyper-reflective layer that represents retinal pigment 
epithelium (RPE) and choriocapillaries. 
 
 Just anterior to RPE - choriocapillaries complex, is a minimally 
reflective layer that represents photoreceptors. Above this layer of 
photoreceptors, are alternating layers of moderate and low 
reflectivity that represents different layers of neurosensory retina. 
The retinal blood vessels within the neurosensory retina shows back 
scatter and also cast a shadow behind. 
 
Image Interpretation28 
a) Objective  
b) Subjective 
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1)  Objective 
 Hyper-reflective lesions are: 
 
Hard exudates : are seen as hyper-reflective shadows in the 
neurosensory retina that completely blocks the reflections from the 
underlying retina. 
 
Blood: Blood causes increasing scattering. Small to thin 
haemorrhages are seen as hyper-reflective lesions. Thick 
haemorrhages blocks the reflections from the underlying structure. 
 
Scars : All fibrotic lesions including disciform scars, choroidal 
rupture scars, healed choroiditis etc are hyper- reflective. 
 
Hypo-reflective lesions are: 
 
Serous fluid : Retinal edema is the commonest cause of reduced 
back scattering and one can actually point out the site of fluid 
accumulation. The serous fluid that is devoid of any particular 
matter, produces an optically empty space with no back scattering. 
 
Hypo-pigmented lesions of RPE. 
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Subjective analysis  
Qualitative., 
Protocols are a)  Normalize 
   b)  Align 
   c)  Median Smoothing 
   d)  Guassian Smoothing 
 
Quantitative 
a) Retinal thickness / volume 
b) Retinal thickness or volume tabular 
c) Retinal thickness / volume change 
 
Advantages of OCT over FFA27-29 
• Non contact, non invasive 
• Time saving technique 
• Totally avoids mild complications like nausea to life 
threatening hypersensitivity reactions seen in FFA. 
• Measurement of retinal thickness by OCT correlate 
more strongly with visual acuity than the presence of 
leakage on angiography. 
• OCT is effective and superior to FFA in demonstrating 
axial distribution of fluid. 
• Can be repeated as many times needed 
• Can quantitatively assess retinal thickness and 
demonstrate any associated RPE structural anomalies 
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beneath the retina which is observed by leakage on 
angiography.  
• Can be done in cases where FFA is contraindicated. 
 
Treatment 
 
 Tina A Scheufele11,17 and Jeffrey et al. advise topical therapy 
consisting of prednisolone acetate and a Nonsteroidal Anti 
Inflammatory Drug (NSAID) qid for at least 6 weeks in all patients 
with pseudophakic CME.  If we observe a response, the patients 
continues therapy until edema resolves. 
 
 Later it is tapered one drop / week. 
 
 A recent small study found no statistic significant difference in 
response of pseudophakic CME to ketorolac alone versus ketorolac 
and prednisolone.10,11 
 
FDA 
 A new twice daily topical NSAID (bromfenac 0.09% (Xibrom 
ista pharmaceutical)) for controlling inflammation after cataract 
surgery.  It’s effectiveness for the patients has been studied.  If 
effective, it may increase patients compliance. 
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If Topical Therapy Fails 
 Topical therapy alone is usually effective in treating routine 
pseudophakic CME, but it may fail in patients who have other risk 
factors.65 
 
• If no improvement occurs after 6 weeks, then the patient is 
treated with periocular or intravitreal steroids. 
• For refractory pseudophakic CME, intravitreal triamcinolone 
acetonide may reduce and improve vision but this effect may 
last only 2 – 4 months.18 
• Pars plana vitrectomy may be indicated when macular edema 
is associated with epiretinal membranes, suspected retained 
lens fragments unresponsive to maximum medical 
therapy.45,60 
• Yannuzzi and Co workers13 (1977) treated established CME 
lasting 4 months or longer orally with indomethacin 25 mg tid 
for 3 weeks and noticed no beneficial effect. 
• Burnett and Co-workers23,30 (1983) used topical % fenoprofen 
for treatment of established CME and several patients showed 
improvement while receiving therapy, with recurrence after 
discontinuation of therapy. 
• Gass and Norton (1969)7,53 also noticed improvements in 
vision in many of their patients who were treated locally and 
systemically with corticosteroids in varying dosages. 
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• Gehring (1968)24 treated CME patients with 20 – 40 mg oral 
prednisolone and noted a beneficial response but recurrence 
of the same following withdrawl. 
 
Prophylactic Treatment 
• Very important in persons undergoing cataract surgery who 
had developed CME after uncomplicated surgery in the other 
eye.64 
• Sholizon34 and co-workers (1979) reported no beneficial effect 
of 25 mg of indomethacin 3 times / day on incidence of CME 
after ICCE. 
• Miyake and Co-workers (1968)35 also demonstrated that 
analysis of aqueous humour from cataract patients during 
post operative period showed elevated level of proteins.  
These levels could be decreased by prior topical 
indomethacin therapy. 
• Fluch AJ et al. (1976) studied prophylaxis of post operative 
CME using NSAIDS 0.5% ketorolac sodium without use of 
concurrent cortiocosteroids and ketorolac sodium given before 
and after the surgery and was found to markedly reduce the 
breakdown of blood aqueous barrier compared with placebo 
solution. 
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PATIENTS AND METHODS 
 
 Patients with Clinical diagnosis of CME who presented to the 
Retina Clinic of Institute of Ophthalmology, Joseph Eye Hospital, 
Trichy between May 1st 2005 to April 30, 2006, were included in this 
study. 
 
Inclusion Criteria 
 Inclusion criteria were all patients with clinical diagnosis of 
CME > 4 weeks following ocular surgery. 
 
Exlusion Criteria 
• CME due to other causes including Diabetic retinopathy, 
Branch Retinal Vein Occlusion, Central Retinal Vein 
Occlusion, Uveitis  
• Patients who did not complete minimum followup period of 3 
months. 
 
 A standard protocol was used to collect and document all the 
details regarding the cases included in this study. 
 
 A detailed information about history and complaints of the 
patients were taken. This included 
o Type / date of surgery 
o Complications of surgery 
o Chief complaints 
o Duration of symptoms  
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 A complete ocular examination was done for all patients which 
included the following : Best corrected visual acuity, Near Vision, 
Slit Lamp Examination of the anterior segment. 
 
 Slit Lamp biomicroscopy of the fundus was done with + 90D 
lens and following were noticed.  Presence of cystoid spaces, 
macular thickening, associated hemorrhages, disc edema, vitreous 
hemorrhage were looked for. 
 
 Digital fundus fluorescein angiography was done using Carl 
Zeiss FF 450 Plus IR digital Camera.  3 ml of 20% sodium 
fluorescein is injected into anterior cubital vein.  A series of 
photographs were taken.  Presence and Extent of leak were noted. 
 
 OCT was done for all the cases, fast macular scan and line 
scans through the fovea were used. Retinal thickness analysis and 
retinal map analysis were done. 
 
 Typical findings in OCT looked for were, cystoid spaces in the 
outer plexiform and inner nuclear layers. 
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Management  
 All patients were treated with ketorolac and prednisolone eye 
drops qid.  If macular thickness failed to reduce by 1 month, patients 
were given posterior subtenon injection of steroid – Triamcinolone 
acetonide 0.1 ml (4 mg). 
 
Follow up 
 All patients were asked to come after 1, 2,  months 
respectively for follow up. At each visit the following were noted.  
Visual acuity, near vision, Amsler’s grid, slit lamp microscopy using 
+ 90 D lens to assess the course of CME.  OCT was done using a 
line scan at each visit. 
 
Statistical Analysis 
 Statistical analysis was done by student ‘t’ test and regression 
analysis.  The value of p < 0.05 was considered significant. 
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RESULTS 
 
 The demographical data includes age, sex of the patients, 
laterality, type of surgery, duration of problem, pretreatment and 
post treatment BCVA, macular thickness. 
 
 The minimum follow up period was 6 months.  Patients 
included in this study were subjected to FFA, OCT at the time of 
presentation and also at first and second review after 1 and 2 
months respectively.  
 
 Twenty patients were included in this study.  Of these 16 were 
male patients and 4 were female patients (Fig. 1). 
 
 Fig. 2 shows age distribution.  Of these 20 patients, 7 patients 
were in 51 – 60 years age group 5 in 71 – 80 years age group, 4 in 
61 – 70 years age group, 3 in 41 – 50 years, 1 in < 40 years age 
group. 
 
 Fig 3 shows laterality.  RE was involved in 55% (n = 11) of 
cases and LE in 45% (n = 9) of cases. 
 
 Fig. 4 shows type of surgeries done.  95% (n = 19) were 
cataract surgeries. Of these 65% (n = 13) were small incision 
cataract surgeries, 25% (n = 5) were phacoemulsifications, 5%              
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(n = 1) were extracapsular cataract surgeries . 5% (n = 1) were 
filtering surgeries. 
 
 Fig. 5 shows the duration of problem.  50% (n = 10) of the 
patients presented between 4 to 6 weeks, 35% (n = 7) of the 
patients presented between 6 to 8 weeks, 10% (n = 2) less than 4 
weeks and 5% (n = 1) more than 8 weeks. 
 
 Fig. 6 shows comparison between pretreatment and post 
treatment BCVA. 
 
 Before treatment, 50% (n = 10) of patients had vision range 
between 6/18 – 6/12, 30% (n = 6) of patients had vision range 
between 6/36 – 6/18, 20% (n = 4) of patients had vision range 
between 6/30 – 6/36. 
 
 Average 0.2886 and standard deviation – 0.132091. 
 
 After 2 months of treatment, 95% of patients (n = 19) had 
vision range between 6/18 – 6/6 and 5% (n = 1) had between 6/36 – 
6/18. 
 
 Fig. 7 shows OCT macular thickness at the time of 
presentation.  At the time of presentation 35% (n = 7) had macular 
thickness between 400 – 500 µ, 15% (n = 3) had macular thickness 
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between 300 – 400 µ, 20% (n = 4) had macular thickness between 
200 – 300 µ and 15% (n = 3) had macular thickness < 200 µ and            
> 500 respectively.  Average was 395 µ and standard deviation was 
158.26893. 
 
 At first time review visit, 60% (n = 12) had macular thickness < 
200 µ, 20% (n = 4) between 300 – 400 µ, 15% (n = 3) > 500 µ and 
5% (n = 1) between 200 – 300 µ.  Average 275 µ and Standard 
deviation 163.32145. 
 
 At second time review visit, 75% (n = 15) had macular 
thickness < 200 µ, 20% (n = 4) between 300 – 400 µ, 5% (n = 1) 
remained between 400 – 500 µ.  Average 275, standard deviation – 
71.031201. 
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Sex of the Patients 
 
Sex No. of Patients Percentage 
Male 
Female 
16 
4 
80 
20 
 
 
Age of the Patients 
 
Age No. of Patients Percentage 
< 40 
41 – 50 
51 – 60 
61 – 70 
70 – 80 
1 
3 
7 
4 
5 
5 
15 
35 
20 
25 
 
 
Laterality 
 
Laterality No. of Patients Percentage 
Right Eye 
Left Eye 
11 
9 
55 
45 
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Type of Surgeries 
 
Type of Surgeries No. of Patients Percentage 
Cataract Surgeries 
 ECCE with IOL 
 SICS with IOL 
 Phaco with IOL 
 
Filtering Surgeries 
 
1 
13 
5 
 
1 
 
5 
65 
25 
 
5 
 
 
Duration of Problem 
Duration No. of Patients Percentage 
< 4 weeks 
4 – 6 weeks 
6 – 8 weeks 
> 8 weeks 
2 
10 
7 
1 
10 
50 
35 
5 
 
 
Pretreatment BCVA 
Pretreatment BCVA No. of Patients Percentage 
6/18 – 6/12 
6/36 – 6/18 
6/60 – 6/36 
< 6/60 
10 
6 
4 
- 
50 
30 
20 
-- 
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Final Visual Acuity 
Final Visual Acuity No. of Patients Percentage 
6/18 – 6/6 
6/36 – 6/18 
6/60 – 6/36 
< 6/60 
19 
1 
- 
- 
95 
5 
- 
- 
 
 
OCT Findings Macular Thickness 
 
Macular 
thickness (µ) 
At 
presentation 
First Visit Second Visit 
< 200 
200 – 300 
300 – 400 
400 – 500 
> 500 
3 
4 
3 
7 
3 
12 
1 
4 
- 
3 
15 
4 
0 
1 
- 
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DISCUSSION 
 
 Optical coherence tomography is a noninvasive, non contact 
imaging system that uses superluminescent diode light source to 
create high resolution, real time, cross sectional tomographic 
images of retina. 
  
In our study it was used in 20 patients with post operative 
CME.  Clinical findings in CME may be subtle without matching with 
visual acuity.  OCT can play an important role in these eyes.  OCT 
can also prove useful for objective followup in these cases. 
 
 In our study, the maximum number of patients were between 
51 – 60 years age group (Mean 61.85 years) which was similar to 
the study done by Jalementel65 and associates (Avg. 69.883).  In 
our study males were  more compared with females (4 : 1).  
Williamson et al.25 in their study have mentioned the sex ratio to be 
1.2 : 1. 
 
 The main risk factors for development of CME in our study 
were PC rent, vitreous loss, AC IOL, ECCE.  Tina A et al.17 in their 
study have mentioned ruptured PC, ECCE, retained lens fragments, 
vitreous loss, iris trauma, AC IOL, Post uveitis as major risk factors. 
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 Duration of problem in our study was between 4 – 6 weeks 
which is similar to observations made by Gass and Norton et al.53 
 
 In our study, slit lamp biomicroscopy showed yellow spot at 
the foveola, loss of foveal depression, thickening of the retina and 
multiple cystoid spaces in the sensory retina.  This is similar to the 
biomicroscopic appearance of CME mentioned by Gass JDM et al.7 
in their study. 
 
 Fundus fluorescein angiogram in our study showed flower 
petal pattern hyperfluorescence in almost all cases Cogan D.G., 
Guzak et al. have described mild parafoveal hyperfluorescence due 
to early leakage in arterio-venous phase.  It was followed by 
increasing hyperfluorescence, coalescence of the focal leaks and 
flower petal pattern of hyper fluorescence. 
 
 In our study, average macular thickness at time of 
presentation was 395 µ. Karocorlu, Murat et al.18 in their study have 
mentioned it as 504 µ. 
 
 Drexlen W, Sattman et al.21 studied patients with cystoid 
macular edema using optical coherence tomography.  They have 
concluded that optical coherence tomography was potentially useful 
as a non-invasive diagnostic technique for quantitative examination 
and objectively monitoring the clinical course of the post operative 
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cystoid macular edema.  They also reported topographic features in 
cystoid macular edema with associated RPE structural anomalies 
beneath the edematous retina, which can be obscured by leakage 
on angiography.  We did not detect any RPE structural anomalies in 
any patients in our study. 
 
 Vanden Moere et al.,19 felt that presence of subretinal fluid, 
gross CME, sponge like retinal thickening and retinal thickness > 
350 µ on OCT correlated well with leakage on FFA (p value 0.01). 
The presence of solitary foveal cyst correlated well will OCT than 
with leaks on FFA.  In our study also, presence of CME on OCT 
correlated well with leakage on FFA.  All 20 patients with CME on 
OCT showed typical flower petal leak on FFA. 
 
 Elesh Kumar Jain, Pankaj Chowdhary et al.22 found intra 
retinal cystic spaces and occasionally a small amount of SRF in 
post operative CME.  OCT may be sufficient for diagnosis in 
patients whose presentation is classic.  However in atypical 
presentation FFA helps the diagnosis by ruling out other causes of 
macular edema such as DR, Venous occlusive diseases, CNVM,  
Idiopathic Juxtafoveal retinal telengicetasia. 
 
 In our study, all the patients were prescribed steroid and 
NSAIDS eye drops.  Posterior subtenon triamcinolone acetonide 
was given if it was not resolved by 1 month.  Burnett and 
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coworkers23 used topical 1% fenoprofen for the treatment of 
established CME in randomized trial.  Gehring24 treated 17 patients 
with CME orally with 20 to 40mg of prednisolone daily and noted a 
beneficial response in 13 cases after average of 5.5 weeks. After 
medication was discontinued, 3 of the 13 patient showed 
recurrences.  In our study no patients had any recurrence. 
 
 Karakorlu et al.18 observed baseline CME to be 504 µ which 
reduced to 264, 240, 232 microns at 1, 3, 6 months respectively.  In 
our study there was a significant decrease in macular thickness 
from presentation to first (p = 0.002) and second visits (p < 0.0001) 
done by OCT.  Measurement of retinal thickness by OCT correlated 
more strongly with visual acuity than presence of leakage on 
angiography. 
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SUMMARY 
 
 In this prospective, non comparative study, 20 eyes of 20 
patients with post operative cystoid macular edema were included.  
FFA was done for all the patients.  Optical coherence was done to 
all patients at presentation and during follow up.  OCT was used to 
quantitatively assess retinal thickness and demonstrate any 
associated RPE structural anomalies beneath the oedematous 
retina, which can be obscured by leakage on angiography.  Line 
scan was done through the leak site. 
 
 Steroids and NSAID eye drops were prescribed to all the 
patients at the time of presentation.  Posterior subtenon 
triamcinolone acetonide was given, if it was not resolved by 1 
month.  Measurements of retinal thickness by OCT correlate more 
strongly with visual acuity than the presence of leakage on 
angiography. The correlation between the macular thickness at 
presentation and at first and second visits was statistically 
significant. 
 
 Optical coherence tomography with its high resolution imaging 
of the retina has a role in the diagnosis and follow up of post 
operative cystoid macular edema.  It is also useful to detect subtle 
cystoid spaces missed by slit lamp biomicroscopy.  It may aid in 
redefining the pathological process in leak site. 
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CONCLUSION 
 
• Optical coherence tomography with its high resolution imaging 
of retina helps in the diagnosis and followup of post operative 
cystoid macular edema. 
• Optical coherence tomography is a noninvasive technique 
(unlike FFA) to detect subtle cystoid spaces which may be 
difficult to detect clinically. 
• Optical coherence tomography objectively monitors the 
course of post operative cystoid macular edema till its 
resolution. 
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ROLE OF OPTICAL COHERENCE TOMOGRAPHY IN MANAGEMENT OF 
POST OPERATIVE CYSTOID MACULAR EDEMA 
 
 
Name :      Age :   Sex : 
 
Address      S. No.  M.R. No. 
 
 
 
Phone  : 
 
 
Complications 
 
 
History of Ocular Surgery 
Type of Surgery  
Intra Operative complications  
Type of IOL  
Current Treatment  
Personal History 
Hypertension  
Diabetes  
Others  
Family History Associated 
Ocular Conditions 
 
General Examination    
B.P.  Pulse Rate  
Cardiac Status  Others  
Ocular Examination  RE LE 
Without 
correction 
  
Best Corrected   
Visual Acuity 
Near Vision   
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IOP 
Anterior Segment    
 Lids and Adnexa   
 Conjuntiva   
 Corena   
 AC   
 Iris   
 Pupils   
 Lens   
Posterior Segment Fundus   
Media 
Colour   
Margins   
CD Ratio   
Disc 
Neuroretinal Rim   
Macula 
Provisional Diagnosis 
 
 
OCT 
 
 
 
 
 
 
 
FFA 
 
 
 
 
 
 
 
 
Management 
Fig. 4. 
 
 
 
Carl Zeiss Digital Camera with Fundus Fluorescein Angiogram 
Fig. 5. 
 
 
 
Carl Zeiss Stratus Optical Coherence Tomogram Model 3000 
PLATE 1 
 
Fundus Fluorescein Angiogram of a post operative cystoid 
macular edema patient showing flower petal pattern of 
hyperfluorescence in late phase 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
PLATE 2 
DIGITAL FUNDUS PHOTOGRAPHS AND OCT (LINE SCAN) OF A 
PATIENT HAVING POST OPERATIVE CYSTOID MACULAR EDEMA  
 
 
 
 
At Presentation 
   
 
 
 
First Review Visit 
   
 
 
 
Second Review Visit 
OCT, at second review visit shows resolution of cystoid spaces and decrease in 
thickening of macula whereas digital fundus photo show loss of foveal depression, 
thickening of retina and few cystoid areas  
PLATE 3 
ROLE OF OPTICAL COHERENCE TOMOGRAPHY IN MANAGEMENT OF 
POST OPERATIVE CYSTOID MACULAR EDEMA 
 
 
At presentation 
 
 
First Review Visit 
 
 
Second Review Visit 
 
Male 16
Female 4
< 40 1
41 - 50 3
51 - 60 7
61 - 70 4
70 - 80 5
RE 11
LE 9
ECCE with 1
SICS with I 13
Phaco with 5
Filtering Su 1
< 4 weeks 2
4 - 6 weeks 10
6 - 8 weeks 7
> 8 weeks 1
Pre TreatmPost Treatment
6/18 - 6/12 11 19
6/36 - 6/18 6 1
6/60 - 6/36 4 0
< 6/60 0 0
< 6/60 0
6/60 - 6/36 0
6/36 - 6/18 1
6/18 - 6/6 19
At presentaFirst Visit Second Visit
< 200 µ 3 12 15
200 - 300 µ 4 1 4
300 - 400 µ 3 4 0
400 - 500 µ 7 0 0
> 500 µ 3 3 1
Fig. 1.  Sex of the Patients
Male, 16, 80%
Female, 4, 20%
Male
Female
01
2
3
4
5
6
7
< 40 41 - 50 51 - 60 61 - 70 70 - 80
Fig. 2.  Age of the Patients
Fig. 3.  Lateraility
RE
55%
LE
45%
02
4
6
8
10
12
14
ECCE with PCIOL SICS with IOL Phaco with IOL Filtering Surgeries
Fig. 4.  Type of Surgeries
01
2
3
4
5
6
7
8
9
10
< 4 weeks 4 - 6 weeks 6 - 8 weeks > 8 weeks
Fig. 5.  Duration of Problem
02
4
6
8
10
12
14
16
18
20
6/18 - 6/12 / 6/6 6/36 - 6/18 6/60 - 6/36 < 6/60
Fig. 6.  Pretreatment and Post Treatment BCVA
Pre Treatment
Post Treatment
02
4
6
8
10
12
14
16
< 200 µ 200 - 300 µ 300 - 400 µ 400 - 500 µ > 500 µ
Fig. 7.  OCT findings Macular Thickness
At presentation
First Visit
Second Visit
OCT Findings
Macular 
thickness in 
microns
VA OCT in microns FFA VA
OCT in 
microns FFA
1 Thomas 400758 75 M LE Phaco with allergan foldable IOL
Improvement after 
cataract surgery then 
decrease in vision
6 Weeks 6/12 N8
Loss of foveal 
depression, 
thickening of retina, 
multiple cystoid
Flower petal - 
hyperfluorescence 
during late phase
492 Predmet e/d qid, Ketlur e/d qid 6/12 380.00
Leak 
present 6/12 130 No leak 6/9 --
2 Pappu 401036 70 M LE SICS with AC IOL / PC Rent
Improvement after 
cataract surgery then 
decrease in vision
4 Weeks 6/18 N12
Loss of foveal 
depression, 
thickening of retina, 
multiple cystoid
Flower petal - 
hyperfluorescence 
during late phase
180 Predmet e/d qid, Ketlur e/d qid 6/24 176.00 No leak 6/18 150 No leak 6/12 --
3 Kaliyamoorthy 382362 50 M RE SICS with PC IOL
Improvement after 
cataract surgery then 
decrease in vision
6 Weeks 6/9 N8
Retinal thicking, 
multiple cystoid 
spaces
Flower petal - 
hyperfluorescence 
during late phase
420 Predmet e/d qid, Ketlur e/d qid 6/12 200.00
Leak 
present 6/9 150 No leak 6/6 --
4 Gopalakrishnan 401996 65 M RE SICS with PC IOL
Improvement after 
cataract surgery then 
decrease in vision
6 Weeks 6/36 N8
Loss of foveal 
depression, multiple 
cystoid spaces
Flower petal - 
hyperfluorescence 
during late phase
605 Predmet e/d qid, Ketlur e/d qid 6/18 360.00
Leak 
present 6/19 210 No leak 6/12 --
5 Ramiah 354113 65 M RE Phaco with IOL
Improvement after 
cataract surgery then 
decrease in vision
8 weeks 6/24p N8
Loss of foveal 
depression, multiple 
cystoid spaces
Flower petal - 
hyperfluorescence 
during late phase
703 Predmet e/d qid, Ketlur e/d qid 6/18 560.00
Leak 
present 6/18 250
Leak 
persists 6/12 --
6 Rajamanickam 401199 55 M LE SICS with PC IOL
Improvement after 
cataract surgery then 
decrease in vision
6 Weeks 6/60 N6
Loss of foveal 
depression, multiple 
cystoid spaces
Flower petal - 
hyperfluorescence 
during late phase
600 Predmet e/d qid, Ketlur e/d qid 6/12 600.00
Leak 
present 6/12 400
Leak 
persists 6/9 --
7 Narasimhan 362679 74 M RE Phaco with PC IOL
Improvement after 
cataract surgery then 
decrease in vision
8 weeks 6/18 N12
Loss of foveal 
depression, multiple 
cystoid spaces
Flower petal - 
hyperfluorescence 
during late phase
476 Predmet e/d qid, Ketlur e/d qid 6/12 650.00
Leak 
present 6/12 160 No leak 6/9 --
8 Kasiammal 314377 72 F RE SICS with PC IOL
Improvement after 
cataract surgery then 
decrease in vision
6 Weeks 6/24 N12 FR dull no obvious cystoid spaces
Flower petal - 
hyperfluorescence 
during late phase
480 Predmet e/d qid, Ketlur e/d qid 6/18 180.00 No leak 6/18 160 No leak 6/12 --
9 Samboornam Jambulinga 408549 56 M RE Trabeculectomy
Defective vision 
following surgery 6 Weeks 6/18 N8
0.8 cupping tinning 
of NRR, loss of 
foveal depression
Flower petal - 
hyperfluorescence 
during late phase
460 Predmet e/d qid, Ketlur e/d qid 6/18 360.00
Leak 
present 6/12 90 No leak 6/9 --
10 Susai 366367 40 M LE SICS with PC IOL
Following cataract 
surgery increase vision 
followed by decreased 
vision
8 weeks 6/60 N8
Loss of foveal 
depression, thinning 
of retina, multiple 
cystoid spaces
Flower petal - 
hyperfluorescence 
during late phase
300 Predmet e/d qid, Ketlur e/d qid 6/18 180.00 No leak 6/12 140 No leak 6/12 --
11 Manickam 494054 60 M RE SICS with PC IOL
Improvement after 
cataract surgery then 
decrease in vision
6 Weeks 6/60 N12
Loss of foveal 
depression, thinning 
of retina, multiple 
cystoid spaces
Flower petal - 
hyperfluorescence 
during late phase
380
Predment e/d qid, 
Ketlur e/d qid 
followed by post 
subtenon
6/18 154.00 No leak 6/12 110 No leak 6/12 --
12 Booshana Bai 513273 57 F RE SICS with PC IOL
Improvement after 
cataract surgery then 
decrease in vision
7 weeks 6/18 N12
Loss of foveal 
depression, thinning 
of retina, multiple 
cystoid spaces
Flower petal - 
hyperfluorescence 
during late phase
203 Predmet e/d qid, Ketlur e/d qid 6/18 154.00 No leak 6/12 106 No leak 6/12 --
13 Arockia Samy 457510 69 M LE Phaco with IOL
Improvement after 
cataract surgery then 
decrease in vision
8 weeks 6/24 N12 FR dull, no cystoid spaces
Flower petal - 
hyperfluorescence 
during late phase
150
Nil Yag 
capsulatomy 
advised
6/18 120.00 No leak 6/9 120 No leak 6/12 --
14 Samuel 459470 80 M LE SICS with IOL
Improvement after 
cataract surgery then 
decrease in vision
6 Weeks 6/18 N12
No foveal 
depression, multiple 
cystoid spaces
Flower petal - 
hyperfluorescence 
during late phase
180 Predmet e/d qid, Acular e/d qid 6/18 120.00 No leak 6/12 120 No leak 6/9 --
15 Chellamuthu 467731 50 M LE ECC with PC IOL
Improvement after 
cataract surgery then 
decrease in vision
8 weeks 6/18 N12
Retinal thickening, 
absence of foveal 
depression
Flower petal - 
hyperfluorescence 
during late phase
207 Predmet e/d qid, Acular e/d qid 6/18 186.00
Leak 
present 6/12 160 No leak 6/12 --
16 Rajasekaran 483692 59 M LE SICS with PC IOL + Corneal Edema
Improvement after 
cataract surgery then 
decrease in vision
10 weeks 6/24 N12
Cystoid spaces + 
absence of foveal 
reflex
Flower petal - 
hyperfluorescence 
during late phase
506 Acular e/d qid + predmet e/d qid 6/24 310.00
Leak 
present 6/18 180 No leak 6/12 --
17 Annapattu 354113 60 F RE SICS with PC IOL
Improvement after 
cataract surgery then 
decrease in vision
4 weeks 6/18 N12
Cystoid spaces + 
absence of foveal 
reflex
Flower petal - 
hyperfluorescence 
during late phase
408 Acular e/d qid + predmet e/d qid 6/36 300.00
Leak 
present 6/18 120 No leak 6/12 --
18 Annapattu 480680 50 F RE Phaco with IOL
Improvement after 
cataract surgery then 
decrease in vision
6 Weeks 6/8 N12
Cystoid spaces + 
absence of foveal 
reflex
Flower petal - 
hyperfluorescence 
during late phase
390 Acular e/d qid + predmet e/d qid 6/36 160.00 No leak 6/12 110 No leak 6/9 --
19 Monohar 278281 70 M LE SICS with PC IOL
Improvement after 
cataract surgery then 
decrease in vision
6 Weeks 6/12 N12
Cystoid spaces + 
absence of foveal 
reflex
Flower petal - 
hyperfluorescence 
during late phase
280 Acular e/d qid + predmet e/d qid 6/36 180.00
Leak 
present 6/12 70 No leak 6/18 --
20 Kumar 268843 60 M RE SICS with PC IOL
Improvement after 
cataract surgery then 
decrease in vision
8 weeks 6/24 N12
Cystoid spaces + 
absence of foveal 
reflex
Flower petal - 
hyperfluorescence 
during late phase
480 Acular e/d qid + predmet e/d qid 6/24 170.00 No leak 6/18 180 No leak 6/9 --
Sex Eye Surgery DoneS. No. Name MRD No. Age Visual Problem Duration BCVA NV Retinal Findings FFA findings
Final 
Visual 
Acuity
Any 
recurren
ce
I II
Management
Male 16
Female 4
< 40 1
41 - 50 3
51 - 60 7
61 - 70 4
70 - 80 5
RE 11
LE 9
ECCE with 1
SICS with I 13
Phaco with 5
Filtering Su 1
< 4 weeks 2
4 - 6 weeks 10
6 - 8 weeks 7
> 8 weeks 1
Pre TreatmPost Treatment
6/18 - 6/12 11 19
6/36 - 6/18 6 1
6/60 - 6/36 4 0
< 6/60 0 0
< 6/60 0
6/60 - 6/36 0
6/36 - 6/18 1
6/18 - 6/6 19
At presentaFirst Visit Second Visit
< 200 µ 3 12 15
200 - 300 µ 4 1 4
300 - 400 µ 3 4 0
400 - 500 µ 7 0 0
> 500 µ 3 3 1
